AnaptysBio, Inc.ANABNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 139.12% |
| Q2 2025 | 1.78% |
| Q1 2025 | -80.54% |
| Q4 2024 | 33.69% |
| Q3 2024 | 29.59% |
| Q2 2024 | -6.20% |
| Q1 2024 | -4.09% |
| Q4 2023 | -13.14% |
| Q3 2023 | 6.37% |
| Q2 2023 | 9.96% |
| Q1 2023 | -67.55% |
| Q4 2022 | 21.16% |
| Q3 2022 | -2.91% |
| Q2 2022 | 10.21% |
| Q1 2022 | -11.42% |
| Q4 2021 | -388.12% |
| Q3 2021 | -1453.85% |
| Q2 2021 | 97.64% |
| Q1 2021 | -153.98% |
| Q4 2020 | 241.57% |
| Q3 2020 | -10.30% |
| Q2 2020 | -160.81% |
| Q1 2020 | 59.23% |
| Q4 2019 | 34.70% |
| Q3 2019 | -29.51% |
| Q2 2019 | -8.53% |
| Q1 2019 | -29.92% |
| Q4 2018 | -6.49% |
| Q3 2018 | -17.18% |
| Q2 2018 | 9.73% |
| Q1 2018 | -119.88% |
| Q4 2017 | 24.52% |
| Q3 2017 | -238.67% |
| Q2 2017 | 76.53% |
| Q1 2017 | -168.49% |
| Q4 2016 | 0.00% |
| Q3 2016 | -100.00% |
| Q2 2016 | 361.49% |
| Q1 2016 | 74.72% |
| Q4 2015 | -140.22% |